Globus Medical, Inc. Class A (GMED) Covered Calls

Globus Medical, Inc. is a leading musculoskeletal technology company that develops and commercializes innovative healthcare solutions for patients with spinal and orthopedic disorders. The company offers a comprehensive portfolio of fusion and motion preservation implants, regenerative biologics, and orthopedic trauma systems. By integrating its robotic-assisted navigation platforms, the firm aims to enhance surgical precision and improve clinical outcomes.

You can sell covered calls on Globus Medical, Inc. Class A to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GMED (prices last updated Fri 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

Globus Medical, Inc. (GMED) is a prominent player in the medical device industry, specializing in the development of tools and technologies for musculoskeletal surgery. Following its transformative merger with NuVasive and the subsequent acquisition of Nevro's neuromodulation assets, Globus has solidified its position as the second-largest spine company globally. The firm’s mission is to provide surgeons with a "total procedural solution," combining advanced implants with sophisticated digital and robotic enabling technologies.

Core Business and Products

The company operates through two primary segments: Musculoskeletal Solutions and Enabling Technologies. The Musculoskeletal segment includes a vast array of hardware—such as pedicle screws, interbody spacers, and joint reconstruction systems—designed for both minimally invasive and open surgical procedures. The Enabling Technologies segment is anchored by the Excelsius™ platform, which features the ExcelsiusGPS™ robotic guidance system. This system integrates real-time imaging and navigation to help surgeons plan and execute complex spinal and orthopedic surgeries with higher degrees of accuracy and consistency.

Competitive Landscape

The orthopedic and spinal markets are highly competitive, dominated by large-cap diversified medical technology firms. Globus competes by focusing on rapid product innovation and superior sales support. Key optionable competitors include:

1. Stryker Corporation: A global leader in medical technology that competes across the spine, trauma, and joint replacement markets.
2. Zimmer Biomet Holdings, Inc.: A major competitor in musculoskeletal healthcare, particularly in joint reconstruction and spinal implants.
3. Boston Scientific Corporation: Competes with Globus in the neuromodulation and pain management space following the integration of the Nevro portfolio.

Strategic Outlook and Innovation

As of 2026, Globus is focused on maximizing the synergies from its recent large-scale acquisitions to drive above-market revenue growth. The strategic integration of NuVasive’s lateral access expertise and Nevro’s spinal cord stimulation technology allows Globus to offer a more holistic approach to patient care, spanning from initial diagnosis and surgery to long-term chronic pain management. Management continues to prioritize research and development, with a specific focus on expanding the Excelsius™ ecosystem to include more automated and AI-driven surgical planning tools.

Innovation at Globus is characterized by its "inspired urgency," a design philosophy aimed at bringing new products to market faster than traditional competitors. Recent advancements include the launch of the ExcelsiusHub™, which streamlines intraoperative imaging and navigation data. By maintaining a lean operational structure and a high-touch independent agent and direct sales force, the company ensures that its technological breakthroughs are effectively translated into clinical success. This evergreen commitment to surgical excellence keeps Globus at the cutting edge of the global musculoskeletal market.

Want more examples? GME Covered Calls | GMF Covered Calls